ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoin... ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. 더 보기
- Inupadenant + carboplatin/pemetrexed in Phase 2 A2A-005 trial demonstrated a 63.9% overall response rate (ORR) and a median PFS of 7.7 months for all evaluable patients across the cohorts...
WATERTOWN, Mass. and GOSSELIES, Belgium, Nov. 26, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and...
- EMA granted clearance to advance belrestotug 400mg + dostarlimab as recommended Phase 3 dose and activate GALAXIES Lung-301 clinical sites in the EU- Interim data from inupadenant Phase 2...
WATERTOWN, Mass. and GOSSELIES, Belgium, Oct. 24, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.115 | -1.55826558266 | 7.38 | 7.53 | 7.17 | 318506 | 7.37134313 | CS |
4 | -1.145 | -13.614744352 | 8.41 | 8.73 | 7.09 | 511019 | 7.75881781 | CS |
12 | -2.765 | -27.5672981057 | 10.03 | 10.22 | 7.09 | 566343 | 8.57040649 | CS |
26 | -7.565 | -51.0114632502 | 14.83 | 18.13 | 7.09 | 528351 | 11.24805639 | CS |
52 | -3.655 | -33.4706959707 | 10.92 | 18.75 | 7.09 | 444222 | 12.23422699 | CS |
156 | -38.695 | -84.1927763272 | 45.96 | 52.43 | 7.09 | 410376 | 17.79222125 | CS |
260 | -12.435 | -63.1218274112 | 19.7 | 52.43 | 7.09 | 361680 | 20.39929701 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관